This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Consiglio Nazionale Delle Richerche, Provincia Italiana Della Congregazione Dei Figli Dell'immacolata Concezione-Istituto Dermopatico Dell'immacolata, Università Degli Studi Di Roma "La Sapienza". Active years: 2012.
Company Filing History:
1 out of 31 
1 out of 2 
1 out of 63 
Years Active: 2012
Title: Stefania D'Atri: Innovator in Proangiogenic Peptide Research
Introduction
Stefania D'Atri is a notable inventor based in Rome, Italy. She has made significant contributions to the field of pharmacology, particularly in the development of peptides with proangiogenic activity. Her work has implications for various medical applications, especially in enhancing vascular growth.
Latest Patents
Stefania D'Atri holds a patent for a peptide derived from vascular endothelial growth factor receptor-1 binding integrin α5β1, which exhibits proangiogenic activity. The patent describes a sequence peptide isolated in the domain II type-immunoglobulin (Type-Ig) of the Vascular Endothelial Growth Factor receptor 1 (VEGF-1). This peptide is usable for the preparation of pharmacological agents aimed at promoting angiogenesis.
Career Highlights
Throughout her career, Stefania has worked with prestigious institutions such as the National Research Council of Italy (Consiglio Nazionale Delle Ricerche) and the University of Rome "La Sapienza" (Università Degli Studi Di Roma "La Sapienza"). Her research has been pivotal in advancing the understanding of vascular biology and therapeutic applications.
Collaborations
Stefania has collaborated with esteemed colleagues, including Simonetta Soro and Veronica Morea. These partnerships have enriched her research and contributed to the successful development of her patented innovations.
Conclusion
Stefania D'Atri's work exemplifies the intersection of innovation and medical research, showcasing her dedication to advancing therapeutic options through her patented discoveries. Her contributions continue to influence the field of pharmacology and vascular biology.